Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma

Frederick W. Thielen(University Medical Center Freiburg), Isaac Corro Ramos(Erasmus University Rotterdam), Nasuh Büyükkaramikli(Erasmus University Rotterdam), Rob Riemsma(Kleijnen Systematic Reviews (United Kingdom)), Gill Worthy(Kleijnen Systematic Reviews (United Kingdom)), Vanesa Huertas Carrera(Kleijnen Systematic Reviews (United Kingdom)), Nigel Armstrong(Kleijnen Systematic Reviews (United Kingdom)), Jos Kleijnen(Kleijnen Systematic Reviews (United Kingdom)), Kate Misso(Kleijnen Systematic Reviews (United Kingdom)), Ching-Yun Wei(Kleijnen Systematic Reviews (United Kingdom)), Debra Fayter(Kleijnen Systematic Reviews (United Kingdom))
PharmacoEconomics
December 13, 2018
Cited by 4


Related Papers